nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—CYP2D6—Hydroxyurea—head and neck cancer	0.17	0.458	CbGbCtD
Trabectedin—CYP2C9—Fluorouracil—head and neck cancer	0.0711	0.191	CbGbCtD
Trabectedin—CYP2D6—Vinblastine—head and neck cancer	0.0602	0.162	CbGbCtD
Trabectedin—CYP3A4—Vinblastine—head and neck cancer	0.0383	0.103	CbGbCtD
Trabectedin—CYP3A4—Docetaxel—head and neck cancer	0.0316	0.085	CbGbCtD
Trabectedin—Neutropenic infection—Docetaxel—head and neck cancer	0.0305	0.0866	CcSEcCtD
Trabectedin—Neutropenic sepsis—Fluorouracil—head and neck cancer	0.0175	0.0498	CcSEcCtD
Trabectedin—Neutropenic sepsis—Docetaxel—head and neck cancer	0.0127	0.036	CcSEcCtD
Trabectedin—Septic shock—Fluorouracil—head and neck cancer	0.0101	0.0286	CcSEcCtD
Trabectedin—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.00763	0.0217	CcSEcCtD
Trabectedin—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.0071	0.0202	CcSEcCtD
Trabectedin—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00702	0.02	CcSEcCtD
Trabectedin—Multi-organ failure—Docetaxel—head and neck cancer	0.00673	0.0191	CcSEcCtD
Trabectedin—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00547	0.0155	CcSEcCtD
Trabectedin—Extravasation—Vinblastine—head and neck cancer	0.00531	0.0151	CcSEcCtD
Trabectedin—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00511	0.0145	CcSEcCtD
Trabectedin—Febrile neutropenia—Fluorouracil—head and neck cancer	0.00505	0.0144	CcSEcCtD
Trabectedin—Mucosal inflammation—Docetaxel—head and neck cancer	0.00396	0.0113	CcSEcCtD
Trabectedin—Necrosis—Fluorouracil—head and neck cancer	0.00387	0.011	CcSEcCtD
Trabectedin—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00376	0.0107	CcSEcCtD
Trabectedin—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00369	0.0105	CcSEcCtD
Trabectedin—Febrile neutropenia—Docetaxel—head and neck cancer	0.00365	0.0104	CcSEcCtD
Trabectedin—Extravasation—Fluorouracil—head and neck cancer	0.00349	0.0099	CcSEcCtD
Trabectedin—Hepatic failure—Hydroxyurea—head and neck cancer	0.00341	0.0097	CcSEcCtD
Trabectedin—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00287	0.00816	CcSEcCtD
Trabectedin—Hepatotoxicity—Docetaxel—head and neck cancer	0.00284	0.00808	CcSEcCtD
Trabectedin—Necrosis—Docetaxel—head and neck cancer	0.0028	0.00795	CcSEcCtD
Trabectedin—Pancytopenia—Vinblastine—head and neck cancer	0.00276	0.00784	CcSEcCtD
Trabectedin—Sepsis—Fluorouracil—head and neck cancer	0.00264	0.0075	CcSEcCtD
Trabectedin—Pancytopenia—Hydroxyurea—head and neck cancer	0.00252	0.00715	CcSEcCtD
Trabectedin—Extravasation—Docetaxel—head and neck cancer	0.00252	0.00715	CcSEcCtD
Trabectedin—Neutropenia—Hydroxyurea—head and neck cancer	0.00248	0.00704	CcSEcCtD
Trabectedin—Agranulocytosis—Vinblastine—head and neck cancer	0.00242	0.00687	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00241	0.00686	CcSEcCtD
Trabectedin—Infestation NOS—Hydroxyurea—head and neck cancer	0.00236	0.00672	CcSEcCtD
Trabectedin—Infestation—Hydroxyurea—head and neck cancer	0.00236	0.00672	CcSEcCtD
Trabectedin—Haemoglobin—Vinblastine—head and neck cancer	0.00234	0.00664	CcSEcCtD
Trabectedin—Haemorrhage—Vinblastine—head and neck cancer	0.00233	0.00661	CcSEcCtD
Trabectedin—Stomatitis—Hydroxyurea—head and neck cancer	0.0023	0.00655	CcSEcCtD
Trabectedin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00223	0.00635	CcSEcCtD
Trabectedin—Pulmonary embolism—Docetaxel—head and neck cancer	0.00219	0.00624	CcSEcCtD
Trabectedin—Injection site reaction—Docetaxel—head and neck cancer	0.00218	0.0062	CcSEcCtD
Trabectedin—Haemoglobin—Hydroxyurea—head and neck cancer	0.00213	0.00606	CcSEcCtD
Trabectedin—Haemorrhage—Hydroxyurea—head and neck cancer	0.00212	0.00603	CcSEcCtD
Trabectedin—Alopecia—Vinblastine—head and neck cancer	0.00206	0.00584	CcSEcCtD
Trabectedin—Pulmonary oedema—Docetaxel—head and neck cancer	0.00195	0.00555	CcSEcCtD
Trabectedin—Angiopathy—Hydroxyurea—head and neck cancer	0.00192	0.00547	CcSEcCtD
Trabectedin—Sepsis—Docetaxel—head and neck cancer	0.0019	0.00541	CcSEcCtD
Trabectedin—Alopecia—Hydroxyurea—head and neck cancer	0.00187	0.00533	CcSEcCtD
Trabectedin—Anaemia—Vinblastine—head and neck cancer	0.00187	0.00532	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00183	0.00521	CcSEcCtD
Trabectedin—Leukopenia—Vinblastine—head and neck cancer	0.00181	0.00515	CcSEcCtD
Trabectedin—Pancytopenia—Fluorouracil—head and neck cancer	0.00181	0.00515	CcSEcCtD
Trabectedin—Hepatic failure—Docetaxel—head and neck cancer	0.00177	0.00504	CcSEcCtD
Trabectedin—Anaemia—Hydroxyurea—head and neck cancer	0.00171	0.00485	CcSEcCtD
Trabectedin—Infestation NOS—Fluorouracil—head and neck cancer	0.0017	0.00483	CcSEcCtD
Trabectedin—Infestation—Fluorouracil—head and neck cancer	0.0017	0.00483	CcSEcCtD
Trabectedin—Stomatitis—Fluorouracil—head and neck cancer	0.00166	0.00471	CcSEcCtD
Trabectedin—Leukopenia—Hydroxyurea—head and neck cancer	0.00165	0.0047	CcSEcCtD
Trabectedin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00162	0.0046	CcSEcCtD
Trabectedin—Agranulocytosis—Fluorouracil—head and neck cancer	0.00159	0.00451	CcSEcCtD
Trabectedin—Anorexia—Vinblastine—head and neck cancer	0.00158	0.00448	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00156	0.00444	CcSEcCtD
Trabectedin—Haemoglobin—Fluorouracil—head and neck cancer	0.00153	0.00436	CcSEcCtD
Trabectedin—Haemorrhage—Fluorouracil—head and neck cancer	0.00153	0.00434	CcSEcCtD
Trabectedin—Oedema—Hydroxyurea—head and neck cancer	0.00151	0.00428	CcSEcCtD
Trabectedin—Infection—Hydroxyurea—head and neck cancer	0.0015	0.00426	CcSEcCtD
Trabectedin—Paraesthesia—Vinblastine—head and neck cancer	0.00148	0.00422	CcSEcCtD
Trabectedin—Dehydration—Docetaxel—head and neck cancer	0.00148	0.00421	CcSEcCtD
Trabectedin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00148	0.0042	CcSEcCtD
Trabectedin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00148	0.00419	CcSEcCtD
Trabectedin—Skin disorder—Hydroxyurea—head and neck cancer	0.00146	0.00416	CcSEcCtD
Trabectedin—Abdominal pain upper—Docetaxel—head and neck cancer	0.00146	0.00414	CcSEcCtD
Trabectedin—Anorexia—Hydroxyurea—head and neck cancer	0.00144	0.00408	CcSEcCtD
Trabectedin—Decreased appetite—Vinblastine—head and neck cancer	0.00144	0.00408	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00143	0.00408	CcSEcCtD
Trabectedin—Constipation—Vinblastine—head and neck cancer	0.00141	0.00402	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00141	0.00399	CcSEcCtD
Trabectedin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00135	0.00384	CcSEcCtD
Trabectedin—Alopecia—Fluorouracil—head and neck cancer	0.00135	0.00383	CcSEcCtD
Trabectedin—Dyspnoea—Hydroxyurea—head and neck cancer	0.00134	0.00382	CcSEcCtD
Trabectedin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00133	0.00377	CcSEcCtD
Trabectedin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00131	0.00372	CcSEcCtD
Trabectedin—Pancytopenia—Docetaxel—head and neck cancer	0.00131	0.00372	CcSEcCtD
Trabectedin—Abdominal pain—Vinblastine—head and neck cancer	0.00131	0.00371	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0013	0.0037	CcSEcCtD
Trabectedin—Fatigue—Hydroxyurea—head and neck cancer	0.0013	0.00369	CcSEcCtD
Trabectedin—Constipation—Hydroxyurea—head and neck cancer	0.00129	0.00366	CcSEcCtD
Trabectedin—Neutropenia—Docetaxel—head and neck cancer	0.00129	0.00366	CcSEcCtD
Trabectedin—Weight decreased—Docetaxel—head and neck cancer	0.00125	0.00354	CcSEcCtD
Trabectedin—Anaemia—Fluorouracil—head and neck cancer	0.00123	0.00349	CcSEcCtD
Trabectedin—Infestation—Docetaxel—head and neck cancer	0.00123	0.00349	CcSEcCtD
Trabectedin—Infestation NOS—Docetaxel—head and neck cancer	0.00123	0.00349	CcSEcCtD
Trabectedin—Hypersensitivity—Vinblastine—head and neck cancer	0.00122	0.00346	CcSEcCtD
Trabectedin—Stomatitis—Docetaxel—head and neck cancer	0.0012	0.0034	CcSEcCtD
Trabectedin—Jaundice—Docetaxel—head and neck cancer	0.0012	0.0034	CcSEcCtD
Trabectedin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00119	0.00339	CcSEcCtD
Trabectedin—Leukopenia—Fluorouracil—head and neck cancer	0.00119	0.00338	CcSEcCtD
Trabectedin—Asthenia—Vinblastine—head and neck cancer	0.00119	0.00337	CcSEcCtD
Trabectedin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00116	0.0033	CcSEcCtD
Trabectedin—Agranulocytosis—Docetaxel—head and neck cancer	0.00115	0.00326	CcSEcCtD
Trabectedin—Myalgia—Fluorouracil—head and neck cancer	0.00113	0.00322	CcSEcCtD
Trabectedin—Diarrhoea—Vinblastine—head and neck cancer	0.00113	0.00321	CcSEcCtD
Trabectedin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00111	0.00316	CcSEcCtD
Trabectedin—Haemoglobin—Docetaxel—head and neck cancer	0.00111	0.00315	CcSEcCtD
Trabectedin—Haemorrhage—Docetaxel—head and neck cancer	0.0011	0.00313	CcSEcCtD
Trabectedin—Dizziness—Vinblastine—head and neck cancer	0.00109	0.00311	CcSEcCtD
Trabectedin—Oedema peripheral—Docetaxel—head and neck cancer	0.00109	0.00309	CcSEcCtD
Trabectedin—Oedema—Fluorouracil—head and neck cancer	0.00108	0.00308	CcSEcCtD
Trabectedin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00108	0.00308	CcSEcCtD
Trabectedin—Asthenia—Hydroxyurea—head and neck cancer	0.00108	0.00307	CcSEcCtD
Trabectedin—Infection—Fluorouracil—head and neck cancer	0.00108	0.00306	CcSEcCtD
Trabectedin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00106	0.00302	CcSEcCtD
Trabectedin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00106	0.00302	CcSEcCtD
Trabectedin—Vomiting—Vinblastine—head and neck cancer	0.00105	0.00299	CcSEcCtD
Trabectedin—Headache—Vinblastine—head and neck cancer	0.00104	0.00294	CcSEcCtD
Trabectedin—Anorexia—Fluorouracil—head and neck cancer	0.00103	0.00294	CcSEcCtD
Trabectedin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00103	0.00293	CcSEcCtD
Trabectedin—Flushing—Docetaxel—head and neck cancer	0.00102	0.00291	CcSEcCtD
Trabectedin—Hypotension—Fluorouracil—head and neck cancer	0.00101	0.00288	CcSEcCtD
Trabectedin—Angiopathy—Docetaxel—head and neck cancer	0.001	0.00284	CcSEcCtD
Trabectedin—Dizziness—Hydroxyurea—head and neck cancer	0.000997	0.00283	CcSEcCtD
Trabectedin—Mediastinal disorder—Docetaxel—head and neck cancer	0.000993	0.00282	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000988	0.00281	CcSEcCtD
Trabectedin—Nausea—Vinblastine—head and neck cancer	0.000982	0.00279	CcSEcCtD
Trabectedin—Insomnia—Fluorouracil—head and neck cancer	0.000981	0.00279	CcSEcCtD
Trabectedin—Paraesthesia—Fluorouracil—head and neck cancer	0.000974	0.00277	CcSEcCtD
Trabectedin—Alopecia—Docetaxel—head and neck cancer	0.000974	0.00277	CcSEcCtD
Trabectedin—Dyspnoea—Fluorouracil—head and neck cancer	0.000967	0.00275	CcSEcCtD
Trabectedin—Mental disorder—Docetaxel—head and neck cancer	0.000966	0.00274	CcSEcCtD
Trabectedin—Malnutrition—Docetaxel—head and neck cancer	0.000959	0.00273	CcSEcCtD
Trabectedin—Vomiting—Hydroxyurea—head and neck cancer	0.000958	0.00272	CcSEcCtD
Trabectedin—Dyspepsia—Fluorouracil—head and neck cancer	0.000955	0.00271	CcSEcCtD
Trabectedin—Rash—Hydroxyurea—head and neck cancer	0.00095	0.0027	CcSEcCtD
Trabectedin—Dermatitis—Hydroxyurea—head and neck cancer	0.000949	0.0027	CcSEcCtD
Trabectedin—Headache—Hydroxyurea—head and neck cancer	0.000944	0.00268	CcSEcCtD
Trabectedin—Decreased appetite—Fluorouracil—head and neck cancer	0.000943	0.00268	CcSEcCtD
Trabectedin—Dysgeusia—Docetaxel—head and neck cancer	0.00094	0.00267	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000937	0.00266	CcSEcCtD
Trabectedin—Back pain—Docetaxel—head and neck cancer	0.000928	0.00264	CcSEcCtD
Trabectedin—Nausea—Hydroxyurea—head and neck cancer	0.000895	0.00254	CcSEcCtD
Trabectedin—Anaemia—Docetaxel—head and neck cancer	0.000887	0.00252	CcSEcCtD
Trabectedin—Syncope—Docetaxel—head and neck cancer	0.00086	0.00245	CcSEcCtD
Trabectedin—Leukopenia—Docetaxel—head and neck cancer	0.000859	0.00244	CcSEcCtD
Trabectedin—Body temperature increased—Fluorouracil—head and neck cancer	0.000858	0.00244	CcSEcCtD
Trabectedin—Loss of consciousness—Docetaxel—head and neck cancer	0.000843	0.0024	CcSEcCtD
Trabectedin—Cough—Docetaxel—head and neck cancer	0.000837	0.00238	CcSEcCtD
Trabectedin—Myalgia—Docetaxel—head and neck cancer	0.000817	0.00232	CcSEcCtD
Trabectedin—Arthralgia—Docetaxel—head and neck cancer	0.000817	0.00232	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000811	0.00231	CcSEcCtD
Trabectedin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000799	0.00227	CcSEcCtD
Trabectedin—Oedema—Docetaxel—head and neck cancer	0.000783	0.00223	CcSEcCtD
Trabectedin—Infection—Docetaxel—head and neck cancer	0.000778	0.00221	CcSEcCtD
Trabectedin—Shock—Docetaxel—head and neck cancer	0.00077	0.00219	CcSEcCtD
Trabectedin—Nervous system disorder—Docetaxel—head and neck cancer	0.000768	0.00218	CcSEcCtD
Trabectedin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000767	0.00218	CcSEcCtD
Trabectedin—Skin disorder—Docetaxel—head and neck cancer	0.000761	0.00216	CcSEcCtD
Trabectedin—Anorexia—Docetaxel—head and neck cancer	0.000746	0.00212	CcSEcCtD
Trabectedin—Diarrhoea—Fluorouracil—head and neck cancer	0.000742	0.00211	CcSEcCtD
Trabectedin—Hypotension—Docetaxel—head and neck cancer	0.000732	0.00208	CcSEcCtD
Trabectedin—Dizziness—Fluorouracil—head and neck cancer	0.000717	0.00204	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000713	0.00203	CcSEcCtD
Trabectedin—Insomnia—Docetaxel—head and neck cancer	0.000708	0.00201	CcSEcCtD
Trabectedin—Paraesthesia—Docetaxel—head and neck cancer	0.000703	0.002	CcSEcCtD
Trabectedin—Dyspnoea—Docetaxel—head and neck cancer	0.000698	0.00198	CcSEcCtD
Trabectedin—Vomiting—Fluorouracil—head and neck cancer	0.00069	0.00196	CcSEcCtD
Trabectedin—Dyspepsia—Docetaxel—head and neck cancer	0.000689	0.00196	CcSEcCtD
Trabectedin—Rash—Fluorouracil—head and neck cancer	0.000684	0.00194	CcSEcCtD
Trabectedin—Dermatitis—Fluorouracil—head and neck cancer	0.000683	0.00194	CcSEcCtD
Trabectedin—Decreased appetite—Docetaxel—head and neck cancer	0.000681	0.00193	CcSEcCtD
Trabectedin—Headache—Fluorouracil—head and neck cancer	0.00068	0.00193	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000676	0.00192	CcSEcCtD
Trabectedin—Fatigue—Docetaxel—head and neck cancer	0.000675	0.00192	CcSEcCtD
Trabectedin—Constipation—Docetaxel—head and neck cancer	0.00067	0.0019	CcSEcCtD
Trabectedin—Nausea—Fluorouracil—head and neck cancer	0.000644	0.00183	CcSEcCtD
Trabectedin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00064	0.00182	CcSEcCtD
Trabectedin—Abdominal pain—Docetaxel—head and neck cancer	0.000619	0.00176	CcSEcCtD
Trabectedin—Body temperature increased—Docetaxel—head and neck cancer	0.000619	0.00176	CcSEcCtD
Trabectedin—Hypersensitivity—Docetaxel—head and neck cancer	0.000577	0.00164	CcSEcCtD
Trabectedin—Asthenia—Docetaxel—head and neck cancer	0.000562	0.0016	CcSEcCtD
Trabectedin—Diarrhoea—Docetaxel—head and neck cancer	0.000536	0.00152	CcSEcCtD
Trabectedin—Dizziness—Docetaxel—head and neck cancer	0.000518	0.00147	CcSEcCtD
Trabectedin—Vomiting—Docetaxel—head and neck cancer	0.000498	0.00141	CcSEcCtD
Trabectedin—Rash—Docetaxel—head and neck cancer	0.000494	0.0014	CcSEcCtD
Trabectedin—Dermatitis—Docetaxel—head and neck cancer	0.000493	0.0014	CcSEcCtD
Trabectedin—Headache—Docetaxel—head and neck cancer	0.000491	0.00139	CcSEcCtD
Trabectedin—Nausea—Docetaxel—head and neck cancer	0.000465	0.00132	CcSEcCtD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—MAPK1—head and neck cancer	0.000166	0.0006	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—MAPK1—head and neck cancer	0.000166	0.0006	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—EGFR—head and neck cancer	0.000166	0.0006	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—EGFR—head and neck cancer	0.000166	0.0006	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—MAPK1—head and neck cancer	0.000165	0.000597	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—EGFR—head and neck cancer	0.000165	0.000597	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—head and neck cancer	0.000164	0.000594	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—HRAS—head and neck cancer	0.000164	0.000593	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—AKT1—head and neck cancer	0.000164	0.000593	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—MAPK3—head and neck cancer	0.000163	0.000588	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—VEGFA—head and neck cancer	0.000162	0.000587	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000162	0.000585	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—MAPK3—head and neck cancer	0.000161	0.000583	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—PIK3CA—head and neck cancer	0.000161	0.000582	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—MAPK3—head and neck cancer	0.00016	0.000577	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—MAPK3—head and neck cancer	0.000159	0.000575	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000155	0.000561	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—AKT1—head and neck cancer	0.000155	0.00056	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—MAPK1—head and neck cancer	0.000155	0.000559	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—EGFR—head and neck cancer	0.000155	0.000559	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—MAPK1—head and neck cancer	0.000153	0.000554	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—EGFR—head and neck cancer	0.000153	0.000554	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000153	0.000554	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000153	0.000553	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—MAPK1—head and neck cancer	0.000152	0.000549	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—EGFR—head and neck cancer	0.000152	0.000549	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000152	0.000548	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—MAPK1—head and neck cancer	0.000151	0.000547	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—EGFR—head and neck cancer	0.000151	0.000547	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—STAT3—head and neck cancer	0.000151	0.000545	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—HRAS—head and neck cancer	0.000149	0.000539	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—HRAS—head and neck cancer	0.000147	0.00053	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—MAPK1—head and neck cancer	0.000146	0.000528	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—EGFR—head and neck cancer	0.000146	0.000528	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000146	0.000526	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000146	0.000526	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—PIK3CA—head and neck cancer	0.000145	0.000524	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000144	0.000522	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—NAT2—head and neck cancer	0.000144	0.000521	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—PIK3CA—head and neck cancer	0.000144	0.000521	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—MAPK3—head and neck cancer	0.000144	0.000521	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000144	0.00052	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—PIK3CA—head and neck cancer	0.000143	0.000518	CbGpPWpGaD
Trabectedin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000142	0.000515	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000142	0.000512	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—AKT1—head and neck cancer	0.000139	0.000501	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—MAPK1—head and neck cancer	0.000137	0.000495	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—head and neck cancer	0.000137	0.000495	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000137	0.000495	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000136	0.000492	CbGpPWpGaD
Trabectedin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000135	0.000488	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KISS1—head and neck cancer	0.000135	0.000488	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—PIK3CA—head and neck cancer	0.000134	0.000485	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—HRAS—head and neck cancer	0.000134	0.000484	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—HRAS—head and neck cancer	0.000133	0.000482	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—HRAS—head and neck cancer	0.000133	0.000482	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—PIK3CA—head and neck cancer	0.000133	0.000481	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—HRAS—head and neck cancer	0.000133	0.00048	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—PIK3CA—head and neck cancer	0.000132	0.000477	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—AKT1—head and neck cancer	0.000132	0.000476	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—PIK3CA—head and neck cancer	0.000131	0.000475	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PTEN—head and neck cancer	0.00013	0.000469	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.00013	0.000468	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—AKT1—head and neck cancer	0.000129	0.000468	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NOTCH1—head and neck cancer	0.000129	0.000467	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—BCL2L1—head and neck cancer	0.000127	0.00046	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—PIK3CA—head and neck cancer	0.000127	0.000459	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—DPYD—head and neck cancer	0.000126	0.000457	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000126	0.000457	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—head and neck cancer	0.000124	0.000449	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—head and neck cancer	0.000123	0.000445	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000122	0.000442	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—head and neck cancer	0.000122	0.000441	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—head and neck cancer	0.000122	0.000439	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—UROD—head and neck cancer	0.00012	0.000435	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—YAP1—head and neck cancer	0.00012	0.000434	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	0.000119	0.00043	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—AKT1—head and neck cancer	0.000118	0.000428	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—AKT1—head and neck cancer	0.000118	0.000426	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—AKT1—head and neck cancer	0.000118	0.000426	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—head and neck cancer	0.000117	0.000424	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—AKT1—head and neck cancer	0.000117	0.000423	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—STAT3—head and neck cancer	0.000116	0.000419	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000112	0.000406	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GRP—head and neck cancer	0.000111	0.000401	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—MAPK3—head and neck cancer	0.000111	0.0004	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	0.00011	0.000398	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—AKT1—head and neck cancer	0.00011	0.000396	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—AKT1—head and neck cancer	0.000109	0.000393	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT6—head and neck cancer	0.000108	0.00039	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NAT2—head and neck cancer	0.000108	0.000389	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—AKT1—head and neck cancer	0.000108	0.000389	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—AKT1—head and neck cancer	0.000107	0.000388	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—VEGFA—head and neck cancer	0.000106	0.000383	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—MAPK1—head and neck cancer	0.000105	0.000381	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—head and neck cancer	0.000105	0.000381	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CASP8—head and neck cancer	0.000104	0.000376	CbGpPWpGaD
Trabectedin—SRC—Membrane Trafficking—AKT1—head and neck cancer	0.000104	0.000375	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—AKT1—head and neck cancer	0.000104	0.000375	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000103	0.000373	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MAPK3—head and neck cancer	0.0001	0.000362	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDH1—head and neck cancer	9.87e-05	0.000357	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	9.72e-05	0.000351	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—YAP1—head and neck cancer	9.54e-05	0.000345	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MAPK1—head and neck cancer	9.54e-05	0.000345	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—head and neck cancer	9.54e-05	0.000345	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—DPYD—head and neck cancer	9.45e-05	0.000342	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	9.19e-05	0.000332	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PIK3CA—head and neck cancer	9.15e-05	0.000331	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.02e-05	0.000326	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—YAP1—head and neck cancer	8.97e-05	0.000324	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—BCL2—head and neck cancer	8.93e-05	0.000323	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.83e-05	0.000319	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.74e-05	0.000316	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IL2—head and neck cancer	8.73e-05	0.000316	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—head and neck cancer	8.46e-05	0.000306	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NAT2—head and neck cancer	8.31e-05	0.000301	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.05e-05	0.000291	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.97e-05	0.000288	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.86e-05	0.000284	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—head and neck cancer	7.66e-05	0.000277	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NAT2—head and neck cancer	7.65e-05	0.000276	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NAT2—head and neck cancer	7.58e-05	0.000274	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—head and neck cancer	7.56e-05	0.000273	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—STAT3—head and neck cancer	7.49e-05	0.000271	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—head and neck cancer	7.47e-05	0.00027	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—head and neck cancer	7.42e-05	0.000268	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL2L1—head and neck cancer	7.41e-05	0.000268	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PTEN—head and neck cancer	7.4e-05	0.000267	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—DPYD—head and neck cancer	7.29e-05	0.000263	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—TYMS—head and neck cancer	7.21e-05	0.00026	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MAPK3—head and neck cancer	7.16e-05	0.000259	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GSTM1—head and neck cancer	7.12e-05	0.000257	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTEN—head and neck cancer	7.1e-05	0.000257	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—MAPK3—head and neck cancer	7.02e-05	0.000254	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—YAP1—head and neck cancer	6.92e-05	0.00025	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GPX1—head and neck cancer	6.82e-05	0.000247	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MAPK1—head and neck cancer	6.81e-05	0.000246	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—head and neck cancer	6.81e-05	0.000246	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP1A1—head and neck cancer	6.75e-05	0.000244	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—DPYD—head and neck cancer	6.71e-05	0.000242	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—MAPK1—head and neck cancer	6.68e-05	0.000241	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—DPYD—head and neck cancer	6.65e-05	0.00024	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—YAP1—head and neck cancer	6.36e-05	0.00023	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MAPK3—head and neck cancer	6.32e-05	0.000228	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—YAP1—head and neck cancer	6.31e-05	0.000228	CbGpPWpGaD
Trabectedin—SRC—Disease—NOTCH1—head and neck cancer	6.14e-05	0.000222	CbGpPWpGaD
Trabectedin—SRC—Immune System—CASP8—head and neck cancer	6.06e-05	0.000219	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MAPK1—head and neck cancer	6.01e-05	0.000217	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—head and neck cancer	6.01e-05	0.000217	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDH1—head and neck cancer	5.99e-05	0.000216	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CA—head and neck cancer	5.8e-05	0.000209	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—head and neck cancer	5.77e-05	0.000209	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—head and neck cancer	5.61e-05	0.000203	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.55e-05	0.0002	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—head and neck cancer	5.47e-05	0.000198	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TYMS—head and neck cancer	5.38e-05	0.000195	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—head and neck cancer	5.36e-05	0.000194	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTM1—head and neck cancer	5.32e-05	0.000192	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CA—head and neck cancer	5.22e-05	0.000189	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL2—head and neck cancer	5.2e-05	0.000188	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.2e-05	0.000188	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GPX1—head and neck cancer	5.1e-05	0.000184	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP1A1—head and neck cancer	5.05e-05	0.000182	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CA—head and neck cancer	5.01e-05	0.000181	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NAT2—head and neck cancer	5e-05	0.000181	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—head and neck cancer	4.83e-05	0.000174	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—head and neck cancer	4.83e-05	0.000174	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.74e-05	0.000171	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—head and neck cancer	4.73e-05	0.000171	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—head and neck cancer	4.64e-05	0.000168	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—head and neck cancer	4.58e-05	0.000165	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—head and neck cancer	4.56e-05	0.000165	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.53e-05	0.000164	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—DPYD—head and neck cancer	4.38e-05	0.000158	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—head and neck cancer	4.31e-05	0.000156	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH1—head and neck cancer	4.3e-05	0.000155	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—head and neck cancer	4.26e-05	0.000154	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—YAP1—head and neck cancer	4.16e-05	0.00015	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMS—head and neck cancer	4.15e-05	0.00015	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.13e-05	0.000149	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTM1—head and neck cancer	4.11e-05	0.000148	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—head and neck cancer	4.09e-05	0.000148	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—head and neck cancer	4.02e-05	0.000145	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—head and neck cancer	3.98e-05	0.000144	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GPX1—head and neck cancer	3.93e-05	0.000142	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP1A1—head and neck cancer	3.89e-05	0.000141	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—head and neck cancer	3.85e-05	0.000139	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMS—head and neck cancer	3.82e-05	0.000138	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMS—head and neck cancer	3.79e-05	0.000137	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.78e-05	0.000137	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTM1—head and neck cancer	3.74e-05	0.000135	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK3—head and neck cancer	3.68e-05	0.000133	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GPX1—head and neck cancer	3.62e-05	0.000131	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GPX1—head and neck cancer	3.59e-05	0.00013	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.58e-05	0.000129	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—head and neck cancer	3.56e-05	0.000129	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1A1—head and neck cancer	3.55e-05	0.000128	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK1—head and neck cancer	3.5e-05	0.000127	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—head and neck cancer	3.5e-05	0.000127	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—head and neck cancer	3.5e-05	0.000127	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK3—head and neck cancer	3.4e-05	0.000123	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK1—head and neck cancer	3.23e-05	0.000117	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—head and neck cancer	3.23e-05	0.000117	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.2e-05	0.000116	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—head and neck cancer	3.04e-05	0.00011	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—head and neck cancer	3e-05	0.000108	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—head and neck cancer	2.96e-05	0.000107	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.92e-05	0.000105	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—head and neck cancer	2.89e-05	0.000104	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—head and neck cancer	2.81e-05	0.000102	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—head and neck cancer	2.81e-05	0.000101	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—head and neck cancer	2.79e-05	0.000101	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—head and neck cancer	2.62e-05	9.46e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—head and neck cancer	2.6e-05	9.38e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—head and neck cancer	2.52e-05	9.09e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMS—head and neck cancer	2.5e-05	9.03e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—head and neck cancer	2.49e-05	9e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—head and neck cancer	2.48e-05	8.97e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—head and neck cancer	2.47e-05	8.93e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.47e-05	8.92e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK3—head and neck cancer	2.38e-05	8.6e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GPX1—head and neck cancer	2.36e-05	8.55e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.34e-05	8.46e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—head and neck cancer	2.32e-05	8.37e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—head and neck cancer	2.29e-05	8.28e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK1—head and neck cancer	2.26e-05	8.18e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—head and neck cancer	2.26e-05	8.18e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.13e-05	7.7e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.11e-05	7.63e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—head and neck cancer	2.02e-05	7.3e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—head and neck cancer	2.02e-05	7.29e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—head and neck cancer	1.96e-05	7.1e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—head and neck cancer	1.9e-05	6.87e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—head and neck cancer	1.86e-05	6.71e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.85e-05	6.67e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—head and neck cancer	1.84e-05	6.65e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—head and neck cancer	1.82e-05	6.57e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—head and neck cancer	1.61e-05	5.8e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—head and neck cancer	1.51e-05	5.45e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.42e-05	5.15e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.39e-05	5.03e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.31e-05	4.73e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.3e-05	4.69e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—head and neck cancer	1.21e-05	4.39e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—head and neck cancer	1.16e-05	4.21e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—head and neck cancer	1.07e-05	3.87e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—head and neck cancer	1.06e-05	3.83e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.57e-06	3.1e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—head and neck cancer	7e-06	2.53e-05	CbGpPWpGaD
